Aaron G. Matlock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aaron G. Matlock has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Amber Cibrario
Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, USA
1 shared publication - Brit Long
Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, MN
1 shared publication - Joshua Allan Garcia
College of Pharmacy, Marshall B. Ketchum University, 2575 Yorba Linda Blvd., Fullerton, CA 92831, USA
1 shared publication - Joshua Lowe
Department of Emergency Medicine, Brooke Army Medical Center , Fort Sam Houston, TX 78234
1 shared publication Joshua Oliver
Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, USA
1 shared publication- Kayvan Moussavi
Department of Pharmacy Practice, College of Pharmacy, Marshall B. Ketchum University, Fullerton, California; Clinical Education, Providence St. Joseph Hospital Orange, Orange, California
1 shared publication
Latest Publications
- 6 May 2021
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 16 (8) , 2231-2241
Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections
Antimicrobial resistance is a growing threat to public health and an increasingly common problem for acute care physicians to confront. Several novel antibiotics have been approved in the past decade to combat these infections; however, physicians may be unfamiliar with how to appropriately utilize them. The purpose of this review is to evaluate novel antibiotics active against resistant gram-negative bacteria and highlight clinical information regarding their use in the acute care setting. This review focuses on novel antibiotics useful in the treatment of infections caused by resistant gram-negative organisms that may be seen in the acute care setting. These novel antibiotics include ceftolozane/tazobactam, ceftazidime/avibactam, meropenem/vaborbactam, imipenem/cilistatin/relebactam, cefiderocol, plazomicin, eravacycline, and omadacycline. Acute care physicians should be familiar with these novel antibiotics so they can utilize them appropriately.
- 6 May 2021
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 16 (8) , 2231-2241
Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections
Antimicrobial resistance is a growing threat to public health and an increasingly common problem for acute care physicians to confront. Several novel antibiotics have been approved in the past decade to combat these infections; however, physicians may be unfamiliar with how to appropriately utilize them. The purpose of this review is to evaluate novel antibiotics active against resistant gram-negative bacteria and highlight clinical information regarding their use in the acute care setting. This review focuses on novel antibiotics useful in the treatment of infections caused by resistant gram-negative organisms that may be seen in the acute care setting. These novel antibiotics include ceftolozane/tazobactam, ceftazidime/avibactam, meropenem/vaborbactam, imipenem/cilistatin/relebactam, cefiderocol, plazomicin, eravacycline, and omadacycline. Acute care physicians should be familiar with these novel antibiotics so they can utilize them appropriately.
- Open Access
- 13 June 2020
- Published by Springer Nature in Cureus
- Vol. 12 (6) , e8592
A Case of Brodie’s Abscess With Tibial Erosion and Extravasation Into Surrounding Soft Tissue
Atraumatic limb pain and limp is a common pediatric presentation in the emergency department in the United States. In a majority of cases, these presentations are benign. However, in cases where pediatric patients are repeatedly presenting for atraumatic limb pain, further investigation is required. We present such the case of a 14-year-old female with acute worsening of progressive atraumatic knee pain who was found to have a Brodie’s abscess, a subacute pyogenic form of osteomyelitis. This is a particularly challenging diagnosis, as it often presents with no associated symptoms such as fever or weight loss. The consequences of missing this diagnosis include permanent disability and potential amputation, but excellent outcomes can be expected for those who undergo timely surgical debridement and irrigation. We discuss the etiology, common presentations, and treatment of this rare but potentially limb-threatening disease in the hope that clinicians will consider this diagnosis in cases of persistent or progressive atraumatic limb pain.
- 13 June 2020
- Published by Springer Nature in Cureus
- Vol. 12 (6) , e8592
Open AccessA Case of Brodie’s Abscess With Tibial Erosion and Extravasation Into Surrounding Soft Tissue
Atraumatic limb pain and limp is a common pediatric presentation in the emergency department in the United States. In a majority of cases, these presentations are benign. However, in cases where pediatric patients are repeatedly presenting for atraumatic limb pain, further investigation is required. We present such the case of a 14-year-old female with acute worsening of progressive atraumatic knee pain who was found to have a Brodie’s abscess, a subacute pyogenic form of osteomyelitis. This is a particularly challenging diagnosis, as it often presents with no associated symptoms such as fever or weight loss. The consequences of missing this diagnosis include permanent disability and potential amputation, but excellent outcomes can be expected for those who undergo timely surgical debridement and irrigation. We discuss the etiology, common presentations, and treatment of this rare but potentially limb-threatening disease in the hope that clinicians will consider this diagnosis in cases of persistent or progressive atraumatic limb pain.